Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Continuum Health Ventures (CHV) is an early-stage venture capital fund established to support startups in the Healthtech, Techbio, and Healthspan Extension (Longevity) sectors. Founded with a mission to identify and back innovative healthcare solutions, CHV focuses on addressing aging and disease prevention through technology and precision medicine. The firm operates globally, with a significant presence in the United States, Canada, the Middle East, India, Japan, South Korea, and Singapore.
Currently, CHV manages a diverse portfolio of companies that are pioneering advancements in healthcare technology. The firm emphasizes personalized interventions and aims to reverse disease hallmarks associated with aging. Their commitment to disrupting traditional healthcare models positions them as a key player in the venture capital landscape.
Continuum Health Ventures invests in startups that operate at the intersection of health and technology. Their primary focus is on companies that aim to digitize healthcare and improve health outcomes through innovative solutions. The firm targets early-stage investments, specifically in the pre-seed, seed, and seed-plus stages, allowing them to engage with startups at critical points in their development.
CHV's investment thesis highlights the importance of personalized interventions, particularly those that can reverse the hallmarks of aging and enhance disease prevention. The firm actively seeks opportunities in healthcare, biotech, and longevity sectors, ensuring a broad geographic reach that includes the United States, Canada, the EU, the Middle East, India, Japan, South Korea, and Singapore.
Continuum Health Ventures boasts a notable portfolio of companies that are making significant strides in health technology and longevity solutions. Key portfolio companies include:
These companies exemplify CHV's commitment to investing in innovative solutions that address critical healthcare challenges.
Ricky Mehra - General Partner. Ricky has extensive experience in venture capital and healthcare, having previously worked with leading firms in the industry.
Daniel Kraft, M.D. - General Partner. Dr. Kraft is a physician and entrepreneur with a background in health technology and innovation.
Michael Apkon, M.D. - Venture Partner. Dr. Apkon has a strong track record in healthcare management and investment.
Dick Foster - Senior Advisor. Dick brings years of experience in venture capital and strategic advisory roles.
Christina Lee - Marketing & Administration. Christina manages marketing efforts and administrative functions within the firm.
Chris Mason, M.D./Ph.D. - Entrepreneur in Residence. Chris is involved in guiding portfolio companies with his expertise in health technology.
Lee Sanders, M.D./M.P.H. - Advisor. Lee provides insights into public health and healthcare innovation.
Dr. Vipan Nikore - Entrepreneur in Residence. Vipan supports startups with his medical and entrepreneurial background.
Ricky Choi, M.D./M.P.H. - Digital Health Advisor. Ricky specializes in digital health solutions and their implementation.
Fernando Ferrer - Big Data Architect. Fernando focuses on data analytics and technology integration.
Prerak Juthani - Fellow. Prerak assists in research and analysis for the firm.
To pitch to Continuum Health Ventures, founders should visit their contact page at Continuum Health Ventures Contact Page. It is essential to include a concise overview of the startup, the problem being addressed, and the proposed solution in the pitch deck. CHV prefers clear and direct communication, and founders should expect a response within a few weeks of submission.
Continuum Health Ventures has been actively engaging with the startup ecosystem, focusing on identifying and supporting innovative healthcare solutions. Their portfolio includes notable companies that are pioneering advancements in neurotechnology, artificial intelligence, and biologics for age-related conditions.
Recent activity includes investments in companies like Ampa Health and Sanctuary AI, which are making significant contributions to their respective fields. CHV continues to explore new opportunities within the healthtech sector, aiming to expand their portfolio with groundbreaking startups.
What are Continuum Health Ventures' investment criteria?
CHV focuses on early-stage startups in the Healthtech, Techbio, and Longevity sectors. They seek companies that leverage technology to improve health outcomes and address aging and disease prevention.
How can I pitch my startup to Continuum Health Ventures?
Founders can pitch their ideas through the contact page on the CHV website. It is recommended to provide a clear overview of the business model, market opportunity, and how the startup aligns with CHV's investment thesis.
What makes Continuum Health Ventures different from other investors?
CHV emphasizes personalized interventions and aims to disrupt traditional healthcare models. Their focus on the intersection of health and technology sets them apart in the venture capital space.
What is the geographic scope of Continuum Health Ventures?
CHV has a global investment reach, including the United States, Canada, the EU, the Middle East, India, Japan, South Korea, and Singapore.
What is the typical check size for investments?
While specific check sizes are not disclosed, CHV primarily invests in pre-seed to seed-plus stages, indicating a focus on early-stage funding.
What kind of post-investment support does Continuum Health Ventures provide?
CHV actively engages with portfolio companies, offering mentorship, operational support, and access to their network to help startups scale effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.